0,938  0,002  NOS2 expression inhibitor
0,885  0,001  Melanin inhibitor
0,878  0,008  Apoptosis agonist
0,820  0,003  Skin whitener
0,816  0,012  Transcription factor NF kappa B inhibitor
0,802  0,004  Caspase 3 stimulant
0,800  0,003  Monophenol monooxygenase inhibitor
0,796  0,004  Antioxidant
0,796  0,005  Chemopreventive
0,795  0,006  Antileukemic
0,804  0,015  Antiinflammatory
0,798  0,009  Antineoplastic (breast cancer)
0,747  0,005  Antineoplastic (glioma)
0,744  0,013  Antineoplastic (lung cancer)
0,730  0,005  AR expression inhibitor
0,726  0,005  Antiosteoporotic
0,703  0,005  Antiprotozoal (Leishmania)
0,709  0,014  Antineoplastic (colorectal cancer)
0,707  0,013  Antineoplastic (colon cancer)
0,699  0,005  Lipoxygenase inhibitor
0,697  0,006  Cardiovascular analeptic
0,691  0,008  Bone diseases treatment
0,689  0,006  Nitric oxide antagonist
0,671  0,004  NOS3 expression enhancer
0,672  0,005  Free radical scavenger
0,669  0,008  Proliferative diseases treatment
0,667  0,012  Antihypercholesterolemic
0,649  0,005  Antineoplastic (glioblastoma multiforme)
0,659  0,016  15-Lipoxygenase inhibitor
0,651  0,009  UGT1A9 substrate
0,632  0,006  Hypoxia-inducible factor 1 alpha inhibitor
0,651  0,030  Caspase 9 stimulant
0,612  0,008  Antineoplastic (brain cancer)
0,607  0,017  Prostate cancer treatment
0,584  0,009  Antiamyloidogenic
0,577  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,586  0,017  Antineoplastic (ovarian cancer)
0,559  0,004  Protein-tyrosine phosphatase inhibitor
0,574  0,024  Antibacterial
0,561  0,021  Respiratory analeptic
0,568  0,029  Alzheimer's disease treatment
0,541  0,009  Vascular (periferal) disease treatment
0,536  0,022  CYP2C19 substrate
0,514  0,010  Antihypertriglyceridemic
0,511  0,021  Radioprotector
0,515  0,029  Immunosuppressant
0,516  0,033  Antiprotozoal
0,505  0,022  Cardioprotectant
0,487  0,006  Antihypotensive
0,493  0,013  Vasodilator
0,496  0,016  CYP1A2 inhibitor
0,495  0,023  Sensitization
0,493  0,021  Apoptosis antagonist
0,482  0,015  Antineoplastic (lymphoma)
0,501  0,050  Antidiabetic
0,501  0,050  Cyclophilin D inhibitor
0,469  0,018  Hypoglycemic
0,476  0,027  Antineoplastic (melanoma)
0,455  0,007  Lipid peroxidase inhibitor
0,452  0,009  Antineoplastic (squamous cell carcinoma)
0,518  0,075  Alpha-glucosidase inhibitor
0,467  0,028  Hepatic disorders treatment
0,463  0,026  Lipoprotein disorders treatment
0,468  0,033  CYP2C19 inhibitor
0,454  0,022  ICAM1 expression inhibitor
0,458  0,028  Antineoplastic (cervical cancer)
0,452  0,024  Antineoplastic (multiple myeloma)
0,435  0,010  Hepatoprotectant
0,429  0,017  Myocardial infarction treatment
0,418  0,010  Platelet adhesion inhibitor
0,414  0,009  VCAM1 expression inhibitor
0,413  0,011  UGT1A3 substrate
0,414  0,019  UDP-glucuronosyltransferase substrate
0,418  0,024  Antiprotozoal (Trypanosoma)
0,425  0,033  Cytotoxic
0,448  0,062  TNF expression inhibitor
0,415  0,031  Cytostatic
0,410  0,036  Antineoplastic (pancreatic cancer)
0,398  0,025  Antiparasitic
0,377  0,005  Estrogen antagonist
0,405  0,033  Chemoprotective
0,405  0,037  NOS3 expression inhibitor
0,372  0,004  Estrogen receptor beta antagonist
0,409  0,041  CYP2D6 substrate
0,381  0,018  Antihelmintic
0,369  0,008  Antidiarrheal
0,399  0,038  Analeptic
0,365  0,004  Estrogen agonist
0,384  0,027  Antineoplastic (renal cancer)
0,357  0,004  Electron transport complex I inhibitor
0,375  0,023  Antineoplastic (lymphocytic leukemia)
0,374  0,029  UGT1A6 substrate
0,365  0,021  UGT1A1 substrate
0,366  0,026  Antiulcerative
0,369  0,031  Antidiabetic symptomatic
0,386  0,049  Antifungal
0,402  0,075  Histamine release inhibitor
0,322  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,350  0,036  Superoxide dismutase inhibitor
0,352  0,039  Antipyretic
0,323  0,015  Topoisomerase II inhibitor
0,311  0,005  Estrogen receptor alpha antagonist
0,324  0,019  Antineoplastic (carcinoma)
0,312  0,007  Neurotrophic factor
0,321  0,018  MAO inhibitor
0,339  0,037  Amyloid beta aggregation inhibitor
0,315  0,016  Amylase inhibitor
0,347  0,057  Antimycobacterial
0,297  0,009  Antihemorrhagic
0,287  0,003  Neuraminidase inhibitor
0,317  0,052  Antineoplastic (non-small cell lung cancer)
0,273  0,013  5-Lipoxygenase inhibitor
0,266  0,008  Beta amyloid protein antagonist
0,284  0,026  Antiviral (Herpes)
0,256  0,004  Neuraminidase (influenza) inhibitor
0,302  0,051  Antineoplastic (liver cancer)
0,319  0,070  12-Lipoxygenase inhibitor
0,273  0,027  Neurotrophic factor enhancer
0,245  0,004  Estrogen receptor beta agonist
0,258  0,018  Heat shock protein 90 antagonist
0,239  0,005  Lipase inhibitor
0,234  0,004  Ca(v)3.1 blocker
0,240  0,011  Topoisomerase II alpha inhibitor
0,283  0,054  Hypolipemic
0,286  0,059  Tumour necrosis factor alpha release inhibitor
0,317  0,092  CYP3A4 substrate
0,230  0,006  Postmenopausal disorders treatment
0,258  0,036  Antimutagenic
0,260  0,038  UGT2B7 substrate
0,235  0,019  MAO B inhibitor
0,246  0,031  Diabetic nephropathy treatment
0,238  0,024  Cyclooxygenase 1 inhibitor
0,236  0,025  Genotoxic
0,235  0,025  UGT2B9 substrate
0,307  0,102  CYP2C9 substrate
0,214  0,009  Gastritis treatment
0,211  0,012  Beta glucuronidase inhibitor
0,242  0,044  P-glycoprotein inhibitor
0,308  0,110  CYP2C9 inhibitor
0,256  0,058  Antimitotic
0,212  0,019  Antibacterial (Helicobacter pylori)
0,194  0,009  Aromatase inhibitor
0,221  0,038  LDLR expression enhancer
0,259  0,083  UGT2B4 substrate
0,331  0,157  Antineoplastic (solid tumors)
0,275  0,105  Antiallergic
0,257  0,088  Spasmolytic
0,218  0,051  UGT1A4 substrate
0,275  0,110  Vasodilator, coronary
0,170  0,008  Leukotriene antagonist
0,195  0,035  Acetylcholinesterase inhibitor
0,202  0,042  UGT2B15 substrate
0,216  0,058  Insulin sensitizer
0,252  0,096  GST M1-1 substrate
0,172  0,018  Dementia treatment
0,233  0,080  Platelet antagonist
0,245  0,095  Antidiabetic (type 2)
0,258  0,109  Antineoplastic (osteosarcoma)
0,167  0,018  Vascular dementia treatment
0,157  0,009  Ornithine decarboxylase inhibitor
0,197  0,052  Succinate dehydrogenase inhibitor
0,152  0,009  Leukotriene synthesis inhibitor
0,177  0,033  Cholesterol synthesis inhibitor
0,186  0,048  Arachidonic acid antagonist
0,179  0,045  Tubulin antagonist
0,150  0,017  ABCA1 expression enhancer
0,231  0,102  5 Hydroxytryptamine uptake stimulant
0,269  0,140  Antiobesity
0,162  0,036  Cystathionine beta-synthase inhibitor
0,238  0,111  Streptokinase A inhibitor
0,149  0,024  Breast cancer-resistant protein inhibitor
0,280  0,157  Antiparkinsonian
0,204  0,082  Antineoplastic enhancer
0,173  0,054  Cyclooxygenase inhibitor
0,254  0,136  Antiprotozoal (Plasmodium)
0,154  0,039  Topoisomerase I inhibitor
0,216  0,103  Antineoplastic (sarcoma)
0,232  0,129  CTGF expression inhibitor
0,152  0,050  Farnesoid X receptor antagonist
0,170  0,068  UGT2B10 substrate
0,164  0,062  Interferon gamma antagonist
0,163  0,063  Phospholipase A2 inhibitor
0,138  0,040  Mucolytic
0,133  0,035  Antineoplastic antibiotic
0,106  0,008  Estrogen receptor alpha agonist
0,245  0,150  Antineoplastic (small cell lung cancer)
0,121  0,028  Phosphodiesterase 4D inhibitor
0,171  0,078  Mutagenic
0,099  0,007  Transcription factor RelA inhibitor
0,161  0,068  Cholinergic
0,137  0,045  MAO A inhibitor
0,124  0,036  Antiviral (SARS coronavirus)
0,124  0,036  Antiviral (Coronavirus)
0,202  0,119  Immunostimulant
0,150  0,068  Protein kinase stimulant
0,146  0,064  Antifungal (Cryptococcus)
0,247  0,167  Antipruritic, allergic
0,110  0,031  Bile acid receptor antagonist
0,105  0,027  Na+ K+ transporting ATPase inhibitor
0,165  0,088  Carcinogenic
0,102  0,027  Peroxisome proliferator-activated receptor gamma agonist
0,141  0,067  Bone formation stimulant
0,084  0,014  Leukotriene B4 antagonist
0,119  0,051  Expectorant
0,071  0,004  Sodium/glucose cotransporter 2 inhibitor
0,075  0,010  Leukotriene C antagonist
0,141  0,076  SULT1A3 substrate
0,127  0,063  DNA polymerase I inhibitor
0,228  0,165  Ulceration
0,115  0,052  Mediator release inhibitor
0,075  0,013  Glucose-6-phosphate translocase inhibitor
0,202  0,143  Antihypoxic
0,074  0,014  Potassium channel Kv1.3 blocker
0,154  0,097  Diabetic retinopathy treatment
0,119  0,062  Microtubule formation inhibitor
0,059  0,005  Leukotriene B4 receptor 1 antagonist
0,066  0,012  Retinoid X receptor agonist
0,214  0,161  Antithrombotic
0,149  0,099  Antipruritic, non-allergic
0,129  0,081  Psychosexual dysfunction treatment
0,072  0,024  Fatty acid synthase inhibitor
0,059  0,011  Retinoid X alpha receptor agonist
0,050  0,004  Leukotriene B4 receptor 2 antagonist
0,155  0,110  Antiviral (Influenza)
0,113  0,068  TRPA1 agonist
0,047  0,005  Sodium/glucose cotransporter inhibitor
0,059  0,018  Cathepsin L2 inhibitor
0,162  0,122  Pneumotoxic
0,177  0,137  DNA damaging
0,117  0,079  Coagulant
0,154  0,118  Abortion inducer
0,101  0,065  Alpha 2c adrenoreceptor antagonist
0,094  0,060  Alpha 2d adrenoreceptor antagonist
0,204  0,171  Vasodilator, peripheral
0,077  0,049  Antitreponemal
0,147  0,120  Antineoplastic (bone cancer)
0,158  0,131  Antiglaucomic
0,033  0,007  Inosine monophosphate dehydrogenase 1 inhibitor
0,147  0,122  Toxic, respiratory center
0,096  0,072  Glutathione S-transferase substrate
0,062  0,038  Androgen agonist
0,057  0,034  Aldose reductase inhibitor
0,117  0,094  Antineoplastic (uterine cancer)
0,115  0,093  Alkaline phosphatase inhibitor
0,075  0,053  SULT1A2 substrate
0,075  0,055  Keratolytic
0,171  0,151  Nitric-oxide synthase stimulant
0,173  0,154  Antituberculosic
0,096  0,077  UGT2B1 substrate
0,059  0,041  Ca(v)3.2 blocker
0,089  0,072  Xanthine oxidase inhibitor
0,057  0,040  Pregnane X receptor antagonist
0,090  0,075  UGT2B11 substrate
0,038  0,027  Retinoid X receptor antagonist
0,042  0,032  Alpha 1L adrenoreceptor agonist
0,106  0,096  Alcohol dehydrogenase substrate
0,054  0,044  Postcoital contraceptive
0,050  0,041  Alpha tubulin antagonist
0,082  0,074  Actinic keratosis treatment
0,024  0,017  Sodium/glucose cotransporter 1 inhibitor
0,032  0,025  Peroxisome proliferator-activated receptor delta antagonist
0,091  0,085  HDL-cholesterol increasing
0,031  0,026  Estrogen-related receptor beta antagonist
0,127  0,122  Prostate disorders treatment
0,049  0,045  Vanilloid 2 antagonist
0,032  0,029  Retinoid X alpha receptor antagonist
0,129  0,127  Ca2+-transporting ATPase inhibitor
0,019  0,017  Retinoic acid alpha receptor antagonist
0,095  0,093  Antihypermotility

